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ORIGINAL ARTICLE
The familial co-aggregation of ASD and ADHD:
a register-based cohort study
L Ghirardi1, I Brikell1, R Kuja-Halkola1, CM Freitag2, B Franke3,4,5, P Asherson6, P Lichtenstein1 and H Larsson1,7
Autism spectrum disorders (ASD) and attention-deﬁcit/hyperactivity disorder (ADHD) frequently co-occur. The presence of a genetic
link between ASD and ADHD symptoms is supported by twin studies, but the genetic overlap between clinically ascertained ASD
and ADHD remains largely unclear. We therefore investigated how ASD and ADHD co-aggregate in individuals and in families to
test for the presence of a shared genetic liability and examined potential differences between low- and high-functioning ASD in the
link with ADHD. We studied 1 899 654 individuals born in Sweden between 1987 and 2006. Logistic regression was used to estimate
the association between clinically ascertained ASD and ADHD in individuals and in families. Stratiﬁed estimates were obtained for
ASD with (low-functioning) and without (high-functioning) intellectual disability. Individuals with ASD were at higher risk of having
ADHD compared with individuals who did not have ASD (odds ratio (OR) = 22.33, 95% conﬁdence interval (CI): 21.77–22.92). The
association was stronger for high-functioning than for low-functioning ASD. Relatives of individuals with ASD were at higher risk of
ADHD compared with relatives of individuals without ASD. The association was stronger in monozygotic twins (OR = 17.77, 95% CI:
9.80–32.22) than in dizygotic twins (OR= 4.33, 95% CI: 3.21–5.85) and full siblings (OR= 4.59, 95% CI: 4.39–4.80). Individuals with
ASD and their relatives are at increased risk of ADHD. The pattern of association across different types of relatives supports the
existence of genetic overlap between clinically ascertained ASD and ADHD, suggesting that genomic studies might have
underestimated this overlap.
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INTRODUCTION
Autism spectrum disorders (ASD) and attention-deﬁcit/hyperactiv-
ity disorder (ADHD) are highly heritable childhood-onset chronic
disorders.1,2 Evidence has accumulated to suggest substantial
overlap between ASD and ADHD traits and symptoms.3,4 Twin
studies suggest that the observed overlap is mainly attributable to
correlated genetic risk factors, both in children and in adults.5–11
ASD and ADHD also seem to share rare genetic risk variants (copy
number variants).12–14 In contrast, recent cross-disorder analyses
from the Psychiatric Genomics Consortium failed to detect
sharing of common single-nucleotide polymorphisms by ASD and
ADHD.15,16
The molecular genetic studies are therefore still inconclusive,
and twin studies have investigated the genetic overlap of ASD and
ADHD trait measures in general population samples, rather than in
clinically deﬁned cases. Large genetically informative studies with
data on clinical diagnoses are therefore needed to investigate
sharing of genetic liability between ASD and ADHD. Thus far, only
two studies have investigated the familial transmission of the
disorders in population-based samples using clinical diagnoses.
One study, which included 435 000 children and their mothers,
found that offspring of mothers with clinically diagnosed ADHD
were at increased risk of ASD.17 However, maternal transmission
comprises genetic as well as environmental prenatal or perinatal
risk factors, and thus this study was unable to disentangle genetic
from non-genetic inﬂuences on the familial overlap between the
disorders. A recent study including 6022 full siblings of 3578 ASD
cases and 22 127 full siblings of 11 775 matched controls found an
increased risk of ADHD in siblings of ASD cases and no difference
in risk between ASD with or without intellectual disability (ID).18
In contrast, other studies have reported differences in the
genetic architecture of ASD related to intelligence. Spontaneously
arising (de novo) genetic mutations have been implicated in ASD
cases with intelligence quotient o100,19 and the rate of these
mutations has been found to be negatively associated with
intelligence quotient in ASD.20
The aim of this study was to investigate the extent to which
ASD and ADHD co-aggregate in individuals and in families,
considering several types of relatives with varying degree of
genetic and environmental relatedness. In addition, we exa-
mined potential heterogeneity in the association between the
disorders by stratifying high-functioning ASD (that is, with
normal intellectual ability) and low-functioning ASD (that is,
with ID).
MATERIALS AND METHODS
The study was approved by the regional ethics review board in Stockholm,
Sweden. The requirement for informed consent was waived, because the
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study was register based, and the included individuals were not personally
identiﬁable at any time.
Study population
We used data from the linkage of several nationwide Swedish registers
using the unique personal identiﬁcation number.21 From the Medical Birth
Register,22 we identiﬁed all individuals born in Sweden between 1987 and
2006 (Figure 1). We linked this information to the Total Population
Register,23 Cause of Death Register and the Multi-Generation Register.24
After having excluded still births, individuals with serious congenital
malformations, those who died or migrated before their seventh birthday,
those whose biological parents were unidentiﬁable and those who were
adopted away, the eligible population included 1 899 654 individuals
(Figure 1). Using information from the Multi-Generation Register, we
identiﬁed seven cohorts of different types of relatives (Figure 1). For each
cohort a data set was created, where each individual occurred at least
twice, once as index person and once as relative.
ASD and ADHD case deﬁnition
We used information from the National Patient Register (NPR),25 in which
diagnoses were recorded according to the International Classiﬁcation of
Diseases, Ninth Revision (ICD-9; 1987–1996) and ICD-10 (1997–2013) and
from the Prescribed Drug Register (PDR; June 2005–2014).26 A recorded
diagnosis of ASD in the NPR (ICD-9 code 299; ICD-10 code F84) at age ⩾ 1
year was used to deﬁne ASD cases.27,28 A recorded diagnosis of ID at age
⩾ 3 years (ICD-9 codes 317–319; ICD-10 codes F70–F79) in ASD cases was
used to deﬁne low- vs high-functioning ASD cases.29 According to ICD-9
and ICD-10 criteria, an ASD diagnosis explicitly precludes an ADHD
diagnosis. Hence, we used additional information from the PDR for the
deﬁnition of ADHD cases, as these are almost exclusively prescribed for
ADHD in children and adolescents in Sweden.30 A recorded diagnosis of
ADHD in the NPR (ICD-9 code 314; ICD-10 code F90) or a recorded
prescription of an ADHD medication in the PDR (Methylphenidate,
Amphetamine, Dexamphetamine, Atomoxetine, Lisdexamfetamine) at
age ⩾ 3 years was used to deﬁne ADHD cases.
Two additional deﬁnitions of cases were used in sensitivity analyses to
assess the robustness of our results. First, ADHD case deﬁnition was based
only on information from the NPR, without using information from the
PDR, to ensure that the possible overlap reﬂects clinically diagnosed cases.
Then ASD and ADHD cases were deﬁned as individuals having at least two
recorded diagnoses17 in the NPR, without using information from the PDR,
to test whether a stricter deﬁnition of cases would lead to similar results.
Covariates
As the administrative prevalence of ASD and ADHD differs in males and
females and has changed over the study period,31 we included sex,
obtained from the Total Population Register, and birth year, obtained from
the Medical Birth Register, as covariates in the analysis.
Statistical analysis
We tested the association between ASD and ADHD (deﬁned as binary
variables) in individuals and in families using logistic regression. Results are
presented as odds ratios (ORs) with two-sided 95% conﬁdence intervals
(CIs). We used cluster-robust variance estimation to adjust the precision of
the estimates (that is, the CIs) for non-independence of data within family
clusters in all the analyses.
Within-individual association
We estimated the ORs of having an ADHD diagnosis in individuals with a
diagnosis of ASD compared with those without a diagnosis of ASD.
Estimates were adjusted for birth year and sex. We also performed the
analyses stratiﬁed by high- and low-functioning ASD diagnosis.
Within-family association
Within-family association was estimated in several types of relatives
(Figure 1) in order to test the existence of a shared familial liability to the
disorders. In this set of analyses, we estimated the ORs of having ADHD in
individuals whose relative(s) had ASD compared with individuals whose
relative(s) did not have ASD. Given that ADHD was the outcome measure,
we refer to individuals in whom ADHD status was evaluated as the
‘outcome person’ and to their relatives as the ‘exposure person’. Estimates
were adjusted for birth year and sex of both the outcome and the
exposure person. We also stratiﬁed the estimates by high- and low-
functioning ASD. This analysis was carried out only in full siblings and full
cousins to ensure sufﬁcient sample size, considering that ID has a low
prevalence, around 1% in our sample.
An increased risk of ADHD in individuals whose relatives had ASD
suggests that aetiological factors shared among relatives (that is, genetic
and environmental risk factors) contribute to the observed association.
Figure 1. Flow diagram of the study population. The ﬂow diagram illustrates how the study population was deﬁned. In each cohort of
relatives, the reported numbers refer to the number of relative pairs.
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Monozygotic twins are genetically identical. Dizygotic twins and full
siblings share on average 50% of their segregating alleles, while half
siblings share on average 25%. Full cousins share on average 12.5% of their
segregating alleles, while half cousins share on average 6.25%. Higher ORs
in full siblings and dizygotic twins than in half siblings and cousins provide
support for the role of genetic inﬂuences. Moreover, as children continue
to live predominantly with their mothers after parental separation,32
maternal half siblings are likely to share family environment to a similar
extent as full siblings and to a larger extent than paternal half siblings.
Maternal half siblings also share pregnancy-related environmental
inﬂuences constant within the same mother. Hence, higher ORs in
maternal half siblings than in paternal half siblings provide support for the
role of shared environmental inﬂuences.
Sensitivity analysis
We obtained unadjusted estimates of the association between ASD and
ADHD (crude ORs) and conducted several additional analyses.
First, we used different deﬁnitions of case, that is, ADHD case deﬁnition
based only on the NPR (Model 1) and ASD and ADHD case deﬁnitions
based on two recorded diagnoses in the NPR (Model 2)17 to test the
robustness of our results to different case deﬁnitions. In these analyses,
information from the PDR was excluded.
Then we tested the alternative hypothesis that a possible familial
association between the two conditions might be better explained by the
presence of the two disorders in the same person, that is, by potential
effects of one disorder on the other, rather than by the presence of a
shared familial liability for the two disorders. For this purpose, we tested
both directions, in which the two disorders may be associated in
individuals. First, we estimated ORs of ADHD in individuals whose relatives
had ASD, compared with those whose relatives did not have ASD,
including ASD in the outcome person as a covariate (Model 3). Then
changing the deﬁnition of outcome and exposure person, we estimated
ORs of ASD in individuals whose relatives had ADHD, compared with those
whose relatives did not have ADHD, including ADHD in the outcome
person as a covariate (Model 4). If the within-family association was purely
driven by direct effects of one disorder on the other, rather than by familial
factors common to the two disorders, the estimates of ORs would be
expected to attenuate to the null or even be reversed in this analysis.33
In addition, estimates stratiﬁed by sex of the outcome and of the
exposure person were obtained for the within-individual association and
the within-family association in full siblings to test possible differences
between males and females in the role of familial liability.
Data management was performed using SAS, version 9.3 (SAS Institute,
Cary, NC, USA); analyses were performed using Stata, version 14.0
(StataCorp., College Station, TX, USA).
Code availability
Computer codes are available upon request from the corresponding
author.
RESULTS
Among the 1 899 654 individuals included in the study, we
identiﬁed 28 468 ASD cases (prevalence 1.50%: 1.20% for high-
functioning ASD, 0.3% for low-functioning ASD) and 82 398 ADHD
cases (4.34%; Table 1), with 13 793 individuals (0.73%) being
comorbid cases (Table 1). Despite precluded from ICD-9 and
ICD-10 criteria, we did identify individuals with both diagnoses
from the NPR (n= 11 837), with the majority of them having both
the diagnoses on the same day at least once during the follow-up
period (n= 10 512; Supplementary Table S1). Prevalence estimates
were consistently above 1% for ASD and around 3% for ADHD,
regardless of the case deﬁnition (Supplementary Table S1). The
prevalence of both the disorders was higher in males (2.03% for
ASD and 5.63% for ADHD) than in females (0.94% for ASD and
2.98% for ADHD; Table 1). Similarly, the prevalence of ASD–ADHD
comorbidity was higher in males (1.01%) than in females (0.43%;
Table 1). Almost half of the individuals with ASD (48%) also had
ADHD, and around 17% of individuals with ADHD also had ASD.
Within-individual association
Individuals with ASD were at higher risk of having ADHD,
compared with those who did not have ASD (OR= 22.33, 95%
CI: 21.77–22.92; Figure 2).
Within-family association
Within-family associations (Figure 2) showed that monozygotic
twins of ASD cases had an increased risk of having ADHD
(OR= 17.77, 95% CI: 9.80–32.22). The association estimated in
monozygotic twins was signiﬁcantly higher (P-valueo0.001) than
the ones estimated in dizygotic twins (OR = 4.33, 95% CI: 3.21–
5.85) and in full siblings (OR = 4.59, 95% CI: 4.39–4.80; Figure 2).
Further, maternal half siblings of ASD cases had an increased risk
of having ADHD (OR= 2.25, 95% CI: 2.07–2.43) (Figure 2). The
magnitude of this association was signiﬁcantly lower (P-
valueo0.001) than the one found in full siblings and signiﬁcantly
higher (P-valueo0.001) than the one found in paternal half
siblings (OR= 1.68, 95% CI: 1.54–1.84; Figure 2). The risk of having
ADHD was also increased in full (OR= 1.64, 95% CI: 1.58–1.71) and
half cousins (OR = 1.30, 95% CI: 1.23–1.38) of ASD cases (Figure 2).
The association was signiﬁcantly stronger in full cousins than in
half cousins (P-valueo0.001).
The magnitude of the association was larger (P-valueo0.001) in
high-functioning ASD cases (that is, with no recorded diagnosis of
ID; OR= 26.08, 95% CI: 25.35–26.83) than in low-functioning ASD
cases (that is, with a recorded diagnosis of ID; OR= 1.25, 95% CI:
1.16–1.34; Table 2). A similar pattern of results was observed in full
siblings and full cousins (Table 2).
Sensitivity analysis
Crude ORs did not differ from those estimated from the adjusted
model (for birth year and sex, Figure 1), with the exception of
within-individual associations, which showed slightly higher ORs,
when no potential confounder was added to the model
(Supplementary Table S2, crude estimates).
Results did not change when the deﬁnition of ADHD was based
only on information from the NPR (Supplementary Table S2 and
Model 1) or when ASD and ADHD cases were identiﬁed using
stricter criteria, that is, at least two diagnoses in the NPR
(Supplementary Table S2 and Model 2), excluding information
from the PDR. Adjustments for comorbidity in the outcome
person, when analysing family co-aggregation of the conditions,
led to a decrease of the ORs, with the largest change observed for
estimates obtained in the cohort of monozygotic twins
(Supplementary Table S2, Models 3 and 4). However, all ORs
remained positive and statistically signiﬁcant, conﬁrming that the
results were not mainly attributable to the effect of within-
individual association.33
Estimates stratiﬁed by sex are presented in Supplem-
entary Table S3. The magnitude of the within-individual associa-
tion was larger (P-valueo0.001) in females (OR = 29.79,
95% CI: 28.46–31.18) than in males (OR= 19.47, 95% CI:
8.90–20.07). No sex differences in the magnitude of within-
family association were detected (Supplementary Table S3).
Table 1. Overall and sex-speciﬁc prevalence of ASD, ADHD and
comorbid cases in the population under study (n= 1 899 654)
Overall Males Females
ASD 28 468 (1.50%) 19 734 (2.03%) 8 734 (0.94%)
ADHD 82 398 (4.34%) 54 759 (5.63%) 27 639 (2.98%)
Comorbid cases 13 793 (0.73%) 9 805 (1.01%) 3 988 (0.43%)
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; ASD, autism
spectrum disorders.
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DISCUSSION
To the best of our knowledge, this is the ﬁrst study investigating
the familial liability to clinically ascertained ASD and ADHD using a
genetically informative design, comparing the association
between the disorders across different types of relatives. We
found evidence of a strong association between ASD and ADHD
within individuals and among individuals belonging to the same
family.
Previous studies have found similar increased risk in ﬁrst-degree
relatives of ASD and ADHD cases. A 2.5-fold increase in the risk of
ASD without comorbid ADHD was found in the offspring of
mothers with ADHD compared with those of mothers without
ADHD.17 A 3.7-fold increase in the risk of ADHD was found in
siblings of ASD cases.18 Our study extends these ﬁndings by
estimating the familial association between ASD and ADHD in
several types of relatives. The pattern of within-family associations
between ASD and ADHD across different types of relatives
reﬂected the decreasing genetic resemblance among them,
conﬁrming ﬁndings from twin studies on ASD and ADHD
traits5–11 and providing strong evidence that genetic factors have
a role in the co-occurrence of clinically ascertained ASD
and ADHD.
The association between ASD and ADHD was weaker among
paternal half siblings than among maternal half siblings. This may
indicate that environmental factors shared by relatives contribute
to the co-occurrence of these conditions, as maternal and paternal
half siblings share the same amount of co-segregating genes, but
maternal half siblings share familial environment to a larger
extent. This interpretation is based on the observation that, after
parental separation, the majority of children tend to live
predominantly with their mothers.32 Although this might change
with time, with children spending more time with both parents,34
other shared environmental factors, such as prenatal factors
constant across pregnancies within the same mother, may
contribute to more similarity among maternal rather than paternal
half siblings. Previous twin studies have found little evidence for
the role of shared environment in the overlap between ASD and
ADHD traits,9,11 but methodological differences such as the use of
ICD-based diagnoses and the comparison of several types of
relatives might explain the inconsistency.
Greater within-individual and within-family associations were
detected for high-functioning ASD compared with low-
functioning ASD. A plausible explanation is that ASD with ID
may represent a more severe ASD phenotype showing less
aetiological overlap with other neurodevelopmental disorders.
Heterogeneity in the aetiological architecture of ASD has been
suggested by the observation that family history of neuropsychia-
tric disease is more strongly associated with high-functioning ASD
than with low-functioning ASD.20 In this group, other types of
genetic mechanisms, such as de novo mutations, may be of
1.00 2.00 4.00 8.00 16.00 34.00
ORs and 95% CI
Half Cousins
Full Cousins
Paternal half siblings 
Maternal half siblings
Full siblings
Dizygotic twins
Monozygotic twins
Within−individual
 1.30 [  1.23 ,  1.38 ]
 1.64 [  1.58 ,  1.71 ]
 1.68 [  1.54 ,  1.84 ]
 2.25 [  2.07 ,  2.43 ]
 4.59 [  4.39 ,  4.80 ]
 4.33 [  3.21 ,  5.85 ]
17.77 [  9.80 , 32.22 ]
22.33 [ 21.77 , 22.92 ]
Adjusted estimates (for birth year and sex)
Figure 2. Within-individual and within-family associations between autism spectrum disorders (ASD) and attention-deﬁcit/hyperactivity
disorder (ADHD). Forest plot illustrating odds ratios (ORs, diamonds) and 95% conﬁdence interval (CI, bars) expressing the association
between ASD and ADHD obtained from the within-individual analysis performed in the whole sample and from the within-family analyses
performed in the cohorts of different relatives. All the estimates were adjusted for birth year and sex. The numbers of observations for each
cohort are: 1 899 654 for the whole sample (that is, within-individual estimates); 8360 for monozygotic twins; 25 310 for dizygotic twins;
1 829 696 for full siblings; 273 924 for maternal half siblings; 269 004 for maternal half siblings; 5 580 328 for full cousins; and 1 251 584 for half
cousins.
Table 2. Within-individual and within-family associations between low- and high-functioning ASD and ADHD
Cohorts Low-functioning ASD High-functioning ASD
OR (95% CI)
Within individual (N Obs= 1 899 654) 1.25 (1.16–1.34) 26.08 (25.35–26.83)
Full siblings (N Obs= 1 829 696) 1.17 (1.03–1.32) 4.93 (4.70–5.17)
Full cousins (N Obs= 5 580 328) 0.93 (0.85–1.02) 1.68 (1.62–1.75)
Abbreviations: ADHD, attention-deﬁcit/hyperactivity disorder; ASD, autism spectrum disorders; CI, conﬁdence interval; OR, odds ratio. ORs and 95% CI
expressing the association between low- and high-functioning ASD (that is, with or without comorbid intellectual disability) and ADHD, obtained from the
within-individual analysis performed in the whole sample and from the within-family analyses performed in the cohorts of full siblings and full cousins. All the
estimates are adjusted for birth year and sex.
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relatively greater importance.19,20 An alternative explanation is
that ASD patients with ID are less likely to receive an additional
diagnosis, even when displaying ADHD symptoms. If this was the
case, the association found here would be an underestimation of
the real overlap in this subgroup. Further research, that combines
information on psychometric measures, may address this issue.
Our results should be considered within the context of the
study strengths and limitations. Using a genetically informative
design and register-based data, we tested the familial association
of ASD and ADHD in the largest population-representative sample
analysed so far. On the other hand, register-based data on
diagnoses and medication prescriptions do not include informa-
tion about symptom proﬁles. Furthermore, ADHD diagnosis from
ICD only captures the combined type of ADHD, which is more
strongly associated with autistic traits.35,36 This might explain the
higher co-occurrence of ASD and ADHD observed in our study
compared with what reported in other population-derived
samples.37,38 In addition, only treatment-seeking individuals were
identiﬁed. As higher psychopathology and poorer functioning
have been observed in ADHD cases displaying ASD traits,39,40
these cases may have higher probability of seeking help and
being clinically reported, compared with those not displaying such
traits. If this was the case, the estimate of the within-individual
association might be inﬂated. Similarly, if relatives of cases are
more likely to seek help compared with relatives of non-cases,
within-family association might be an overestimation of the
familial liability shared by the disorders.
In sensitivity analyses, all the ORs remained statistically
signiﬁcant after adjusting for comorbidity in the outcome person,
conﬁrming that the results were not mainly attributable to the
effect of within-individual association (that is, a direct effect of one
disorder on the other). Although we cannot completely rule out
the action of this type of mechanism, this further supports our
main hypothesis that the observed co-occurrence of ASD and
ADHD in individuals and families is (at least partly) due to shared
liability between the disorders. The large decrease observed in
monozygotic twins might reﬂect unstable estimates due to power
issues, given the smaller size of this cohort compared with the
others.
Our results were not dependent on either source of information
or case deﬁnition. When considering only information from the
NPR, we obtained similar prevalence and association estimates,
conﬁrming the validity of the use of information about ADHD
medication from PDR to identify ADHD cases30 and suggesting
that the observed overlap most likely reﬂects true comorbidity.
Similarly, a more stringent deﬁnition of ADHD and ASD cases,
requiring at least two recorded diagnoses17 in the NPR, did not
lead to different results.
Additional analyses showed a stronger within-individual asso-
ciation in females than in males, in accordance with a previous
study of children with ADHD, in which the percentage of females
having clinically relevant autistic traits was higher than the
percentage of males.41 However, we did not ﬁnd support for sex
differences in shared familial liability between ASD and ADHD, as
within-family association estimated in full siblings did not differ
depending on the sex of the exposing sibling. According to the
female protection hypothesis, that is, that females clinically
referred with neurodevelopmental disorders present a higher
‘mutational burden’ compared with males,42 we were expecting to
ﬁnd higher rates of ADHD in siblings of female ASD cases
compared with siblings of male ASD cases. Such an effect was not
supported by another study conducted in a population-based
sample, which investigated familial association between ASD and
other neuropsychiatric disorders.18
In conclusion, our study provides robust and representative
estimates of the association between ASD and ADHD in
individuals and in families, supporting the importance of genetic
and family-shared environmental inﬂuences. These results suggest
that genomic studies might have underestimated the genetic link
between ASD and ADHD.15,16 Such studies may have suffered
from insufﬁcient sample size to detect genetic overlap. Another
potential explanation for the low genetic link between ASD and
ADHD in previous genomic studies is the use of strict exclusion
criteria for comorbidity. Future molecular genetic studies with a
focus on within-disorder heterogeneity and cross-disorder simila-
rities may thus beneﬁt not only from larger sample size but also
from less stringent exclusion criteria about comorbidities;43,44 such
a study design could be used to disentangle disorder-speciﬁc from
cross-diagnostic genetic effects.44 In addition, either genetic
imprinting or shared environmental effects have to be assumed
owing to the higher risk in maternal half siblings compared with
paternal half siblings. Thus our results emphasise the importance
of assessing environmental exposures in future research on the
aetiology of neurodevelopmental disorders.
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